Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease

BACKGROUND: Enteric fistula is one of the penetrating features in Crohn’s disease (CD). This study aimed to clarify the prognostic factors for the efficacy of infliximab (IFX) treatment in luminal fistulizing CD patients. METHODS: We retrospectively included 26 cases diagnosed with luminal fistulizi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ye, Zhang, Runfeng, Liu, Wei, Sun, Yinghao, Li, Jingnan, Yang, Hong, Lv, Hong, Li, Yue, Tan, Bei, Sun, Xiyu, Qian, Jiaming, Li, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997017/
https://www.ncbi.nlm.nih.gov/pubmed/36890451
http://dx.doi.org/10.1186/s12876-023-02676-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997017/
https://www.ncbi.nlm.nih.gov/pubmed/36890451
http://dx.doi.org/10.1186/s12876-023-02676-9

Ejemplares similares